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Edited by Jesus AvilaAbstract Evidence has been gathered to suggest that trace
amounts of copper induce neurotoxicity by interaction with
elevated cholesterol in diet. Copper treatment alone showed no
signiﬁcant learning and memory impairments in behavioral
tasks. However, copper-induced neurotoxicity was signiﬁcantly
increased in mice given elevated-cholesterol diet. Trace amounts
of copper decreased the activity of SOD and increased the level
of malondialdehyde (MDA) in the brain of cholesterol-fed
mouse. Copper also caused an increase in amyloid precursor pro-
tein (APP) mRNA level and the activation of caspase-3 in the
brain of cholesterol-fed mice. The apoptosis-induced nuclear
DNA fragmentation was detected in the brain of those mice by
terminal deoxynucleotidyl transferase (TdT)-mediated dUTP
nick-end-labeling staining. These ﬁndings suggest that trace
amounts of copper induce neurotoxicity in cholesterol-fed mice
through apoptosis caused by oxidative stress.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Copper is an essential metal for all living organisms and is a
component of many metalloproteins such as antioxidant
enzyme Cu–Zn superoxide dismutase (Cu, Zn, -SOD) and
cytochrome oxidase [1,2]. However, copper also plays a role
in the pathogenesis of neurodegenerative disease such as Alz-
heimer’s disease (AD) [3]. The amyloid precursor protein
(APP) of AD has a copper binding domain (CuBD) located
in the N-terminal cysteine-rich region. APP binds to copper
with high aﬃnity and reduces Cu(II) to Cu(I) [4–6]. It has been
suggested that APP may function as a redox active metallopro-Abbreviations: Ab, amyloid-b peptide; APP, amyloid precursor pro-
tein; CuBD, copper binding domain; Cu, Zn,-SOD, Cu–Zn superoxide
dismutase; MDA, malondialdehyde; ROS, reactive oxygen species;
TUNEL, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP
nick-end-labeling
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doi:10.1016/j.febslet.2006.10.072tein or as an antioxidant because of its ability to chelate copper
ions [7–9].
Cholesterol plays a central role in the development and
maintenance of the brain and nervous system [10,11]. Human
brain makes up only 2% of the body’s weight, yet contains
nearly 25% of its cholesterol. But more evidences have
implicated a role of cholesterol in AD [11]. According to the
cholesterol-Alzheimer’s hypothesis, high cholesterol causes
the buildup of amyloid plaques, the pathological hallmark of
AD [12,13]. The b-amyloid (Ab) deposition that constitutes
the plaques is composed of a 39–42 amino acid peptide, which
is the proteolytic product of APP [14,15]. It has been reported
that addition of trace amounts of copper to the drinking water
of cholesterol-fed rabbits induces accumulation of Ab and for-
mation of senile plaque (SP)-like structures [16]. Oxidative
stress is considered to be involved in the onset and progression
of AD. The neurotoxicity of Ab is also associated with cellular
injury following reactive oxygen species (ROS) exposure
[17,18]. Application of antioxidants such as Vitamin E has
been demonstrated to prevent neurotoxicity from Ab [19].
Nevertheless, the precise relationship among APP, copper,
and cholesterol, and the biochemical role of copper, choles-
terol and oxidative stress in neurotoxicity and development
of neurodegenerative diseases are still unclear. In this study,
the eﬀects of trace amounts of Cu(II) treatment on Cu, Zn-
SOD, malondialdehyde (MDA), and the behavior of mice were
investigated. The mechanism of neurotoxicity by the cotreat-
ment with Cu(II) and cholesterol was proposed.2. Materials and methods
2.1. Subjects
Eight-week-old male Kunming strain mice (30.65 ± 4.25 g) were
purchased from the Branch of National Breeder Center of Rodents
(Shanghai). Prior to experiments mice had free access to food and
water and were kept under constant conditions of temperature
(23 ± 1 C) and humidity (60%). Ten mice were housed per cage on a
12-hour light/dark schedule (lights on 08:30–20:30). After acclimatiza-
tion to the laboratory conditions, mice received a combination of food
and water comprising normal chow or normal chow plus 2% choles-
terol and distilled water or distilled water plus copper (0.21 ppm) for
8 weeks prior to testing. In brief, mice were divided randomly into 4
groups: (1) control, (2) copper sulfate, (3) cholesterol, and (4) copper
sulfate plus cholesterol. All experiments were performed in compliance
with the Chinese legislation on the use and care of laboratory animals
and were approved by the respective university committees for animal
experiments. After the behavioral testing, mice were sacriﬁced and
brain tissues were immediately collected for experiments or stored at
70 C for later use.blished by Elsevier B.V. All rights reserved.
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2.2.1. Open ﬁeld test. Based on spontaneous exploration of a novel
environment, the open ﬁeld is one of the most widely used behavioral
tests. The open ﬁeld apparatus was a circular arena (50 cm in diameter,
30 cm in height) made of wood laminated with light-grey resin and illu-
minated with a single 40 W bulb (3000 lux) placed 2.8 m above the cen-
tre of it. The bottom of the arena was divided into 21 equal-area grid
cells by white lines. Tests were performed in the breeding room from
8:30 to 16:00 as described previously [20]. The behavioral parameters
were analysed as the following: (1) ambulation: the number of grids
crossed in the arena during the observation period; (2) rearing: the
number of times the mouse stands on its hind legs; (3) leaning: the
number of times the mouse placed one or two forelimbs on the wall
of the arena; (4) grooming: the number of times the mouse ‘washes’ it-
self by licking, wiping, combing or scratching of any part of the body.
2.2.2. Step through test. The step-through passive avoidance appa-
ratus consisted of an illuminated chamber (11.5 cm · 9.5 cm · 11 cm)
attached to a darkened chamber (23.5 cm · 9.5 cm · 11 cm) containing
a metal ﬂoor that could deliver footshocks. The two compartments
were separated by a guillotine door. The illuminated chamber was lit
with a 25 W lamp. The step through test was performed as described
previously [20].
2.2.3. Morris water maze. The experimental apparatus consisted of
a circular water tank (100 cm in diameter, 35 cm in height), containing
water (23 ± 1 C) to a depth of 15 cm, which was rendered opaque by
adding ink. A platform (4.5 cm in diameter, 14.5 cm in height) was
submerged 1 cm below the water surface and placed at the midpoint
of one quadrant. The pool was located in a test room, which contained
various prominent visual cues. The test was performed as described
previously [20]. Each mouse received three training periods per day
for four consecutive days. Latency to escape from the water maze
(ﬁnding the submerged escape platform) was calculated for each trial.
On day 5, the probe test was carried out by removing platform and
allowing each mouse to swim freely for 60 s. The time that mice spent
swimming in the target quadrant (where the platform was located dur-
ing hidden platform training), and in the three non-target quadrants
(right, left and opposite quadrants), was measured, respectively. For
the probe trials, the number of times crossing over the platform site
of each mouse was also measured and calculated. All data were re-
corded with a computerized video system.2.3. Preparation of tissue samples
2.3.1. Tissue homogenates. For biochemical studies, animals were
deeply anesthetized and sacriﬁced. Brains were promptly dissected
and perfused with 50 mM (pH 7.4) ice-cold phosphate buﬀered saline
solution (PBS). Brains were homogenized in 1/5 (w/v) PBS containing
a protease inhibitor cocktail (Sigma–Aldrich, MO, USA) with 10
strokes at 1200 rpm in a Potter homogenizer. Homogenates were di-
vided into two portions and one part was directly centrifuged at
8000 · g for 10 min to obtain the supernatant. Supernatant aliquots
were used to determine brain MDA levels and protein contents. The
second part of homogenates was sonicated four times for 30 s with
20 s intervals using a VWR Bronson Scientiﬁc sonicator, centrifuged
at 5000 · g for 10 min at 4 C, and the supernatant was collected
and stored at 70 C for determination of superoxide dismutases
(SOD) enzyme activities. Protein contents were determined by using
the BCA assay kit (Pierce Biotechnology Inc., Rockford, IL).
2.3.2. Collection of brain slice. The mice were perfused transcar-
dially with 25 ml of normal saline (0.9%). The brain tissues were ﬁxed
in a fresh solution of 4% paraformaldehyde (pH 7.4) at 4 C for 4 h,
incubated overnight at 4 C in 100 mM sodium phosphate buﬀer
(pH 7.4) containing 30% sucrose; and embedded in Optimal Cutting
Temperature (OCT, Lecia, CA, Germany). Cryosections (12 lm) were
collected on 3-aminopropyl-trimethoxysilane-coated slides (Sigma–
Aldrich) and stored at 70 C.Fig. 1. (A) Trace amounts of copper decrease the SOD activity in the
brain of cholesterol-fed mice. (B) Trace amounts of copper increase the
MDA level in the brain of cholesterol-fed mice. Data are means ±
S.E.M. **P < 0.01, as compared to the control group.2.4. Assay of SOD activity
Chemicals used in the assay, including xanthine, xanthine oxidase,
cytochrome c, bovine serum albumine (BSA) and SOD, were pur-
chased from Sigma Chemical Company. SOD activity was measured
according to the method described previously [20]. Solution A was pre-
pared by mixing 100 ml of 50 mM PBS (pH 7.4) containing 0.1 mM
EDTA and 2 lmol of cytochrome c with 10 ml of 0.001 N NaOH
solution containing 5 lmol of xanthine. Solution B contained 0.2 Uxanthine oxidase/ml and 0.1 mM EDTA. Fifty microliter of a tissue
supernatant was mixed with 2.9 ml of solution A and the reaction
was started by adding 50 ll of solution B. Change in absorbance at
550 nm was monitored. A blank was run by substituting 50 ll of ultra
pure water for the supernatant. SOD levels were expressed as U/mg
protein with reference to the activity of a standard curve of bovine
Cu, Zn, -SOD under the same conditions.
2.5. Measurement of malondialdehyde (MDA) level
Chemicals: n-Butanol, thiobarbutiric acid, 1, 1, 3, 3-tetramethoxy-
propane and all other reagents were purchased from Sigma Chemical
Company. The level of MDA in brain tissue homogenates was deter-
mined using the method of Uchiyama and Mihara [21]. Half a milliliter
of homogenate was mixed with 3 ml of H3PO4 solution (1%, v/v) fol-
lowed by addition of 1 ml of thiobarbituric acid solution (0.67%,
w/v). Then the mixture was heated in a water bath at 95 C for
45 min. The colored complex was extracted into n-butanol, and the
absorption at 532 nm was measured using tetramethoxypropane as
standard. MDA levels were expressed as nmol per mg of protein.
2.6. RT-PCR and in situ hybridization
2.6.1. RNA isolation, RT-PCR, plasmid construction and in vitro
synthesis of riboprobes. The whole brains of mice were dissected after
euthanasia with an overdose of the anesthetic agent. Total mRNA was
extracted from mice brain with Trizol (Invitrogen, Carlsbad, CA,
USA). About 50–100 mg of brain material was used for RNA isolation
with 1 ml of Trizol Reagent. AMV reverse transcriptase (Promega,
Madison, WI, USA), and oligo-(dT)15 primers (Promega) were used
for generating total cDNA. PCR cloning of APP695 (GenBank Acces-
sion No. NM_007471) was performed with primers containing EcoRI
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lab) restriction enzyme cut site. APP mRNA levels were also measured
by semi-quantitative RT-PCR [22]. The sequences of PCR primers
were as follows:
5 0ATC GAATTC CCAACCAGCCAGTGACCATCCAGA 3 0 (for-
ward primer)
5 0ATC GGATCC CTTCCTCAACATCAGCCACTTCCT 3 0 (reverse
primer)
For control purposes, levels of b-actin mRNA were measured in the
same tubes using the following primers:
5 0-TGAACCCTAAGGCCAACCGTGAA-3 0 (forward primer)
5 0-TCTGCTGGAAGGTGGACAGTGAG-3 0 (reverse primer)
The size of the ampliﬁed b-actin mRNA fragment was 735 base-pair
(bp).
PCR was performed in a reaction volume of 50 ll, using the Expand
High-Fidelity PCR-system (Roche Diagnostics Corporation, India-
napolis, IN, USA) according to the instructions of the manufacturer.
For PCR, the initial melting temperature was 95 C for 5 min, followed
by 35 cycles at 94 C for 30 s, 55 C for 30 s and 72 C for 1 min, with a
ﬁnal extension at 72 C for 10 min. The PCR products were visualized
on a 1% agarose gel, puriﬁed with a Wizard SV Gel and PCR Clean-
Up System kit (Promega) and then cloned into pGEM3Z plasmids
(Promega). The insert was sequenced and veriﬁed to be a 456 bpFig. 2. In situ hybridization analysis of APP mRNA in cerebral cortex of m
their drinking water; (C) cholesterol-fed mice; and (D) cholesterol-fed mice
boxes in panels A, B , C, and D are enlarged in panels E, F, G, and H forcDNA, corresponding to bases 408–863 of the APP mRNA. To make
APP riboprobe templates, the recombination plasmid containing the
456 bp APP cDNA fragment was linearized with EcoRI and tran-
scribed with SP6 RNA polymerase to generate a complementary
RNA (cRNA) antisense probe complementary to mouse APP mRNA.
A sense probe was generated by linearizing the plasmids with BamHI,
and transcribed with T7 RNA polymerase. The antisense and sense
(control) riboprobes were labeled by the in vitro transcription in a
reaction mixture containing DIG RNA Labeling mix (Roche Diagnos-
tics Corporation), 1 lg of linearized plasmids and 20 units of SP6 or T7
RNA polymerase (Promega) according to the manufacturer’s protocol.
After transcription, the template DNA was digested with 40 units of
DNase I for 15 min at 37 C. Unincorporated labeling molecules were
removed by centrifugation.
2.6.2. In situ hybridization of brain sections. The in situ hybridiza-
tion was carried out as described (Roche Diagnostics Corporation,
Indianapolis, IN, USA), with all steps being performed under
RNAse-free conditions prior to hybridization [20]. Hybridization
signals were visualized with sheep polyclonal anti-digoxigenin Fab
fragments conjugated to alkaline phosphatase using 4-nitro blue tetra-
zolium chloride and 5-bromo-4-chloro-3-indolyl phosphate as sub-
strates for color reactions in alkaline phosphatase buﬀer (0.1 M
Tris–HCl, pH 9.0, 0.1 M NaCl, 50 mM MgCl2).ice. (A) The vehicle control; (B) mice with copper (0.21 ppm) added to
with copper added to their drinking water. The areas indicated in the
clearer visualization. Scale bars: 100 lm (A–H).
Fig. 3. In situ hybridization analysis of APP mRNA in hippocampus
of mice. (A) The vehicle control; (B) mice with copper (0.21 ppm)
added to their drinking water; (C) cholesterol-fed mice; and (D)
cholesterol-fed mice with copper added to their drinking water. The
areas indicated in the boxes in panels A, B, C, and D are enlarged in
panels E, F, G, and H for clearer visualization. Scale bars: 100 lm (A–
H).
Fig. 4. RT-PCR analysis of the APP mRNA level in mouse brain. (A)
The APP mRNA in the brain of the vehicle control, mice with copper
(0.21 ppm) added to their drinking water, cholesterol-fed mice, and
cholesterol-fed mice with copper added to their drinking water was
detected by semi-quantitative RT-PCR; (B) The relative levels of APP
mRNA in mouse brain was calculated and expressed as the ratio of
APP mRNA to b-actin. Data are means ± S.E.M. (three independent
experiments).
Fig. 5. Immunohistochemistry analysis of activated caspase-3 in the
cerebral cortex of mice. (A) The vehicle control; (B) mice with copper
(0.21 ppm) added to their drinking water; (C) cholesterol-fed mice; and
(D) cholesterol-fed mice with copper added to their drinking water.
The areas indicated in the boxes in panels A, B , C, and D are enlarged
in panels E, F, G, and H for clearer visualization. Scale bars: 100 lm
J. Lu et al. / FEBS Letters 580 (2006) 6730–6740 6733(A–H). (I) The histogram showed the number of cleaved caspase-3
positive cells in cerebral cortex of mice. Data are means ± S.E.M.
(n = 7). **P < 0.01, as compared to the control group.2.6.3. RT-PCR analysis. Semi-quantity of detected bands on the aga-
rose gel was calculated using the Scion Image analysis software (Scion
Corp., Frederick, MD, USA). Each optical density was normalizedusing each corresponding b-actin density as an internal control and
we standardized the optical density of vehicle control for relative com-
parison as 1 to compare other groups.
2.7. Immunohistochemistry
Mouse tissues were sectioned after being ﬁxed in 4% paraformalde-
hyde. For immunohistochemistry, endogenous peroxidase activity in
the sectioned tissues was blocked with 3% H2O2, and non-speciﬁc
binding sites were blocked with 3% normal goat serum (Chemicon
International Inc., Temecula, CA). The sections were incubated with
anti-cleaved caspase-3 (Cell Signaling Technology Inc., Beverly, MA,
USA) diluted 1:50 in Tris-buﬀered saline (TBS) containing 1% goat
serum at 4 C overnight. Subsequently, biotinylated goat anti-rabbit
IgG secondary antibody (diluted as per the recommendations of the
supplier; Vector Laboratories Inc., Burlingame, CA, USA) was ap-
plied, followed by incubation for 1 h with an avidin–biotin–horserad-
6734 J. Lu et al. / FEBS Letters 580 (2006) 6730–6740ish peroxidase complex (ABC Elite Kit, Vector Laboratories Inc.).
Horseradish peroxidase was reacted with diaminobenzidine and
H2O2 for 5 min to yield a permanent deposit. Stained whole mounts
were rinsed in distilled water, mounted on 3-aminopropyl-trimethoxy-
silane-coated slides, air-dried overnight, dehydrated in ethanol, cleared
in xylene, and cover-slipped with cytoseal (Stephens Scientiﬁc, Kala-
mazoo, MI). The speciﬁcity of the staining was assessed by omitting
the primary antibody. The number of caspase 3-positive cells in
0.01 mm2 was estimated by blind manual counting of seven regions
located at a consistent position per section.
2.8. TUNEL assay
For terminal deoxynucleotidyl transferase (TdT)-mediated dUTP
nick-end-labeling (TUNEL) staining, the standard protocol for frozen
sections was followed (BD ApoAlert DNA Fragmentation assay kit,
BD Biosciences Clontech, Palo Alto, CA). The sections were immersed
in a Coplin jar containing fresh 4% formaldehyde/PBS, and incubated
at room temperature for 5 min. The sections were washed twice with
PBS for 5 min. The liquid was allowed to drain thoroughly and the
slides were placed on a ﬂat surface. Each section was covered with
100 ll of 20 lg/ml Proteinase K solution (Section 3) and incubated at
37 C for 5 min. After 2 washes of 5 min each with PBS, the sections
were transferred into a Coplin jar containing 4% formaldehyde/PBS,Fig. 6. Immunohistochemistry analysis of activated caspase-3 in the hippoca
added to their drinking water; (C) cholesterol-fed mice; and (D) cholesterol-f
in the boxes in panels A, B , C, and D are enlarged in panels E, F, G, and H
showed the number of cleaved caspase-3 positive cells in hippocampus of m
control group.and then washed in PBS again. The cells were covered in equilibration
buﬀer (from the kit) and equilibrated at room temperature for 5 min.
The equilibrate buﬀer was drained, and TdT incubation buﬀer was
added to the tissue sections. To perform the tailing reaction, the slice
was placed in a dark and humidiﬁed 37 C incubator for 1 h. The
tailing reaction was terminated by immersing the samples in 2 · SSC
at room temperature for 15 min. Samples were washed three times with
PBS for 5 min to remove unincorporated ﬂuorescein-dUTP. Finally,
strong, nuclear green ﬂuorescence in apoptotic cells was observed on
a ﬂuorescent microscopy (Leica Microscopy Systems, Heidelberg,
Germany) equipped with a standard ﬂuorescein ﬁlter (520 ± 20 nm).
All cells stained with PI exhibit strong red cytoplasmic ﬂuorescence
when viewed at 620 nm. The number of TUNEL-positive and total cells
in 0.01 mm2 was estimated by blind manual counting of seven regions
located at a consistent position per section. The relative proportion
of apoptotic (TUNEL-positive) cells in vehicle control was set as 1.
2.9. Statistic analysis
All statistical analyses were performed using the SPSS software, Ver-
sion 11.5. Analysis of variance (ANOVA) was carried out with New-
man–Keuls or Tukey’s HSD post hoc test for multiple comparisons.
Data were expressed as means ± S.E.M. Statistical signiﬁcance was
set at P < 0.05.mpus of mice. (A) The vehicle control; (B) mice with copper (0.21 ppm)
ed mice with copper added to their drinking water. The areas indicated
for clearer visualization. Scale bars: 100 lm (A–H). (I) The histogram
ice. Data are means ± S.E.M. (n = 7). **P < 0.01, as compared to the
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3.1. Copper potentiates the cholesterol-induced decrease in
SOD activity and increase in MDA level
Oxidative stress in the brain occurs when the generation of
ROS overwhelms the ability of the endogenous antioxidant
system including SOD, glutathione peroxidase etc., to removeFig. 7. In situ detection of fragmented DNA (TUNEL assay) in the cerebr
photographed using a ﬂuorescence microscope with either a propidium iod
vehicle control mice; (D–F) mice with copper (0.21 ppm) added to their drin
copper added to their drinking water. Apoptotic cells appear ﬂuorescent g
that apoptotic cells appear yellow and non-apoptotic cells appear red (
relative proportion of TUNEL-positive cells in cerebral cortex of mice. Dat
group.ROS, subsequently leading to cellular damage. Therefore, low
antioxidant capacity could result in brain tissue being suscepti-
ble to oxidative damage. Interestingly, copper and cholesterol
co-treatment signiﬁcantly decreased the activity of SOD and in-
creased the level of MDA in the mouse brain, but there were no
signiﬁcant eﬀect by copper or cholesterol treatment alone as
compared to distilled water and normal chow treatment (Fig. 1).al cortex of mice. The brain tissues were processed for TUNEL and
ide (PI) ﬁlter alone (left), or a FITC ﬁlter alone (middle). (A–C) the
king water; (G–I) cholesterol-fed mice; (J–L) cholesterol-fed mice with
reen with the FITC ﬁlter alone (middle). The merged image shows
right). Scale bars: 100 lm (A–L). (M) The histogram showed the
a are means ± S.E.M. (n = 7). **P < 0.01, as compared to the control
6736 J. Lu et al. / FEBS Letters 580 (2006) 6730–67403.2. Copper induces the expression of APP mRNA in the
brain of cholesterol-fed mice
The expression of APP mRNA in hippocampus and cerebral
cortex of mice was analyzed by in situ hybridization and Semi-
quantity RT-PCR. The expression of APP mRNA decreased
slightly in the cerebral cortex of mice treated with copper alone
(Fig. 2). Intriguingly, the same trace amounts of copper signif-
icantly induced the expression of APP mRNA in cerebral cor-
tex of cholesterol-fed mice as compared to the control group.
The intensiﬁed signals were also detected in the CA1, CA2
and CA3 regions of hippocampus (Fig. 3). Consistent with
the observations in the cerebral cortex, the copper treatmentFig. 8. In situ detection of fragmented DNA (TUNEL assay) in the hipp
photographed using a ﬂuorescence microscope with either a propidium iodide
control mice; (D–F) mice with copper (0.21 ppm) added to their drinking wa
added to their drinking water. Apoptotic cells appear ﬂuorescent green with
cells appear yellow and non-apoptotic cells appear red (right). Scale bars:
TUNEL-positive cells in hippocampus of mice. Data are means ± S.E.M. (nincreased the expression of APP mRNA in the hippocampus
of cholesterol-fed mice. Furthermore, Semi-quantitative
RT-PCR showed that copper and cholesterol co-treatment
increased the level of APP mRNA in the mouse brain
(Fig. 4).
3.3. Copper induces the activitation of caspase-3 and apoptosis
in the brain of cholesterol-fed mice
Caspase activation has been identiﬁed as a hallmark of
apoptosis, a form of programmed cell death. Caspase-3, a pro-
totype eﬀector caspase, is able to degrade a number of ‘‘death
substrates’’. Activated caspase-3 immunohistochemistry is anocampus of mice. The brain tissues were processed for TUNEL and
(PI) ﬁlter alone (left), or a FITC ﬁlter alone (middle). (A–C) the vehicle
ter; (G–I) cholesterol-fed mice; (J–L) cholesterol-fed mice with copper
the FITC ﬁlter alone (middle). The merged image shows that apoptotic
100 lm (A–L). (M) The histogram showed the relative proportion of
= 7). **P < 0.01, as compared to the control group.
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the cerebral cortex and the hippocampus of mouse brain, we
examined the activation of caspase-3 by the method of immu-
nohistochemistry (Figs. 5 and 6). We found that copper treat-
ment alone non-signiﬁcantly reduced the cleaved caspase-3
positive cells number in the cerebral cortex and the CA1,
CA2, CA3 and dentate gyrus regions of hippocampus. Similar
to the ﬁndings of in situ hybridization of APP mRNA, copper
treatment signiﬁcantly induced the activation of caspase-3 in
these brain regions in cholesterol-fed mice [cerebral cortex:
F(3,24) = 9.926, P < 0.01; hippocampus: F(3,24) = 10.064,
P < 0.01].
This study sought further evidence for apoptosis in brain tis-
sue of mice co-treated with copper and cholesterol. Detection
of DNA fragments in situ using the TUNEL assay is now com-
monly used to investigate apoptosis. Enhanced apoptosis was
observed in the brain of mice co-treated with trace amounts
of copper and elevated cholesterol [cerebral cortex: F(3,24) =
7.929, P < 0.01; hippocampus: F(3,24) = 9.591, P < 0.01] (Figs.
7 and 8).Fig. 9. Open ﬁeld activity as measured by (A) the number of grid
crossing, (B) rearing and leaning, and (C) grooming. All values are
expressed as means ± S.E.M. *P < 0.05 vs. vehicle control. Scale bars:
100 lm.3.4. Copper intensiﬁes cholesterol-induced learning and
memory impairment
3.4.1. Open ﬁeld. Open ﬁeld activity was used to evaluate
locomotor activity, exploratory behavior, and anxiety in mice
with various treatments. There was a non-signiﬁcant increase
in open ﬁeld activity in mice with copper added to drinking
water, and a decrease in mice with addition cholesterol added
to the diet, as compared with mice on distilled water and nor-
mal chow. However, signiﬁcant decrease was found between
the mice co-treated with cholesterol and copper and the mice
on distilled water and normal chow in grid crossing
[F(3,28) = 6.279, P < 0.05], rearing and leaning [F(3,28) =
5.575, P < 0.05], and grooming [F(3,28) = 5.826, P < 0.05],
respectively (Fig. 9).
3.4.2. Step through. In the training trial, the latencies for
entry into the dark compartment did not diﬀer signiﬁcantly
among groups. In the 72-hour-retention trial, there was no sig-
niﬁcant diﬀerence between the mice treated with either copper
or cholesterol and those on normal chow and distilled water.
However, the co-treatment of copper and cholesterol signiﬁ-
cantly decreased the retention latencies [F(3,28) = 4.239, P <
0.05] (Fig. 10).
3.4.3. Morris water maze. During the training session, all
groups of mice improved their performance as indicated
by the decreasing escapelatencies across successive days
(Fig. 11A). However, the escape latency was generally higher
in cholesterol-fed mice given copper in their drinking water
than in any other group of mice [day 1: F(3,28) = 0.635,
P > 0.05; day 2: F(3,28) = 6.183, P < 0.05; day 3: F(3,28) =
4.190, P < 0.05; day 4: F(3,28) = 3.867, P < 0.05]. Note that
mice of every treatment started at the same level of perfor-
mance (no signiﬁcant individual eﬀect was observed for the
ﬁrst three trials of day 1).
The withdrawal of the platform induced a general tendency
to swim, preferentially in the quadrant where the platform was
previously located as opposed to other quadrants. In terms of
relative time spent in the four equivalent quadrants, the ANO-
VA revealed this preference displayed by all groups except the
group co-treated with cholesterol and copper [Control:
F(3,28) = 6.567, P < 0.05; Cu(II): F(3,28) = 16.161, P < 0.001;
Cholesterol: F(3,28) = 6.816, P < 0.05; Cu(II)/Cholesterol:
F(3,28) = 1.960, P > 0.05] (Fig. 11B). Furthermore, the analy-
sis conducted on the crossings onto the platform zone, in the
quadrant where the platform was previously located, revealedFig. 10. Performance in the step-through tasks. All values are
expressed as means ± S.E.M. *P < 0.05 vs. vehicle control. Scale bars:
100 lm.
Fig. 11. Performance in the Morris water maze. All values are expressed as means ± S.E.M. (A) Comparison of latencies to platform during 4
training days. (B) Comparison of numbers of crossing over the platform zone on day 5. *P < 0.05 vs. vehicle controls. (C) Comparison of the time
spent in target quadrant with other quadrants on day5. *P < 0.05, **P < 0.01, ***P < 0.001 vs. target quadrant. Scale bars: 100 lm.
6738 J. Lu et al. / FEBS Letters 580 (2006) 6730–6740a marked preference among controls and mice treated with
copper added to the drinking water or cholesterol added to
the diet alone (no signiﬁcant eﬀect); but mice co-treated with
copper and cholesterol did not show this preference
[F(3,28) = 5.455, P < 0.05 vs. vehicle control] (Fig. 11C).4. Discussion
AD is a progressive neurodegenerative disorder character-
ized by progressive memory impairment as a consequence of
loss of synapses and development of amyloid plaques and
neuroﬁbrillary tangles. Recent evidence has been gathered to
reveal that Ab precipitation and toxicity in AD are caused
by abnormal interaction with metal ions, especially Cu, Zn
and Fe. It has been reported that the addition of trace amounts
of copper (0.12 ppm) to water given to cholesterol-fed rabbits
can induce Ab accumulation, formation of SP-like structures,
and can markedly impair trace conditioning. According to
the Environmental Protections Agency maximum contaminant
level goal (MCLG) for copper (not exceeds 1.3 ppm) in drink-
ing water, this ﬁnding implies that tap water has suﬃcient cop-
per contamination to impact the pathophysiology of AD.
Cholesterol is an integral component of all eukaryotic cell
membranes and is essential for normal cellular functions[23,24]. In the nerve system, cholesterol is also vital to the
brain and is an important factor in the formation of synapses
[25]. However, increasing evidence suggests that excess brain
cholesterol plays a role in the pathophysiology of Alzheimer
disease (AD) [26]. In our studies, the ANOVA failed to reveal
any signiﬁcant diﬀerence in performance among mice treated
with copper or cholesterol alone and the controls by behav-
ioral tasks. Interestingly, we found that trace amounts of cop-
per could markedly impair learning and memory abilities of
cholesterol-fed mice (Figs. 9–11).
Further studies were carried out to investigate the mecha-
nism of copper-induced neurotoxic eﬀects on the cholesterol-
fed mice. The brain is known to possess the highest oxygen
metabolic rate of any organ in the body [27]. The transition
metals, such as copper and iron, are vital for normal cellular
function. However, if not strictly regulated, copper is a poten-
tial source of free radical production in the brain [4]. Our result
showed that trace amounts of copper could slightly enhance
the activity of SOD and reduce the level of MDA in the mouse
brain, but these changes were not revealed by ANOVA.
Intriguingly, trace amounts of copper facilitated decrease of
SOD activity and increase of MDA level in the brain of choles-
terol-fed mice. These results indicate that elevated levels of
both copper and cholesterol induce brain oxygen damages
(Fig. 1).
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have evolved complex metal transport systems that deliver
Cu and Fe to metalloenzymes and proteins, such as SOD
and APP. APP has a copper binding domain (CuBD), which
can mediate the oxidative stress in neurons by reducing cop-
per(II) to copper(I) [28]. Furthermore, our results showed that
trace amounts of copper could induce higher level of APP
mRNA expression than distilled water without copper in the
cerebral cortex and the hippocampus of cholesterol-fed mouse
(Figs. 2 and 3).
Recent studies also suggest that amyloid-b peptide (Ab1–42)
can sequester copper(II) and prevent the metal ion from gener-
ating damaging ROS. It was reported that Cu and Zn are
enriched in Ab deposits in AD patients [29]. Possibly, Ab is in-
volved in the metal clearance to lower the enhanced level of
copper. But the aberrant processing of APP that leads to the
aggregation and toxicity of Ab1–42 is a key molecular event
in the pathogenesis of Alzheimer’s disease. Consistant with
the previous reports, we found that the increase of Ab was
accompanied by the increase of APP mRNA expression (data
not shown here).
Caspases are crucial mediators of apoptosis. These enzymes
play a dual role in proteolytic processing of APP and the
resulting propensity for Ab deposit, as well as in the ultimate
apoptosic death of neurons in Alzheimer disease. APP is di-
rectly cleaved within the cytoplasmic tail by caspases, predom-
inantly caspase-3, resulting in the formation of Ab [30].
Increased level of activated caspase-3 was detected in cerebral
cortex and hippocampus of mice co-treated with cholesterol
and copper. This may lead to the increased deposition of Ab
and, consequently, the neurotoxicity (Figs. 5 and 6).
Neuronal loss is prominent in certain brain regions in AD
patients, and DNA fragmentation in neurons is often used to
measure the neuronal loss in a neurodegenerative disease.
Using the TUNEL assay, we detected apoptosis-induced frag-
mented DNA in the brain of cholesterol-fed mice, and the
DNA fragmentation was signiﬁcantly increased by the co-
treatment with copper (Figs. 7 and 8). This ﬁnding further
suggests that the neurotoxicity eﬀect of copper and cholesterol
co-treatment is mediated, at least in part, by the apoptosis of
neurons.
In conclusion, cholesterol-induced neurotoxicity and deﬁcits
in learning and memory abilities could be augmented by
cotreatment wih trace amounts of copper, which may be med-
iated via oxidative stress induced apoptosis.Acknowledgements: This work is supported by Foundation for Univer-
sity Key Teacher by the Ministry of Education of PR China, Grants
from Key Laboratory of Jiangsu Province, Grants from Key discipline
of Jiangsu Province and Grants from Qing Lan Project of Jiangsu
Province, PR China.References
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